These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11727011)

  • 1. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations.
    Kaider AS; Coulam CB
    Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
    Molo MW; Rawlins RG; Binor Z; Kelly M; Radwanska E
    J Reprod Med; 1995 Jun; 40(6):418-22. PubMed ID: 7650652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
    Lukaszuk K; Liss J; Lukaszuk M; Maj B
    Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
    Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
    Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
    Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate.
    Yang JH; Chen HF; Lien YR; Chen SU; Ho HN; Yang YS
    J Reprod Med; 2001 May; 46(5):434-8. PubMed ID: 11396368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles].
    Paredes Chávez FC; Barros Delgadillo JC; Ochoa Rueda SS; Barroso Villa G; Villalobos Acosta S; Sánchez Solís V; Osorio Caballero M; Gaviño Gaviño F
    Ginecol Obstet Mex; 2004 Dec; 72():645-55. PubMed ID: 15813475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study on the relationship between luteal phase serum sex hormone levels and pregnancy outcome in in vitro fertilization embryo transfer cycle].
    Tian X; Zhang L; Yang C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):484-6. PubMed ID: 10806749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
    Ferrari B; Barusi L; Coppola F
    J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.